Evidence map›Paper›PMID 40809568›Full record

ArticleAfrican health sciences2024

The impact of COVID-19-induced lockdowns on Antiretroviral-Therapy (ART) adherence by HIV/AIDs patients on ART in the city of Bulawayo in Zimbabwe.

Mjabuli Jamela, Macide Artac Özdal

Abstract read
In one paragraph

Article in African health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mjabuli JamelaEuropean University of Lefke, Lefke, Northern Cyprus TR-10 Mersin, Turkey, 99010.
Macide Artac ÖzdalEuropean University of Lefke, Lefke, Northern Cyprus TR-10 Mersin, Turkey, 99010.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Zimbabwe has one of the highest HIV prevalence rates in the world. HIV treatment was initiated in 2004 and expanded to 94% coverage rate by the 2020. Objectives: i) to determine the level of treatment adherence during COVID-19-induced lockdowns and ii) to investigate the key determinants of adherence to ART during COVID-19-induced lockdowns. Methods: The cross sectional study involved 392 people living with HIV (PLHIV) and was conducted at nine health facilities in Bulawayo City. Data was analysed using the Shapiro-wilk test for normality, Chi-squared test, Kaiser-Meyer-Olkin (KMO), Bartlett's test, exploratory factor analysis, reliability analysis, scree plot, correlation analysis and multiple linear regression analysis. Results: 94.6% of the respondents took their ARTs on time, and 90.6% did not miss any treatment review. The factors influencing treatment adherence were health systems (beta value 0.334), Family support (beta value 0.138) and knowledge/understanding of treatment (beta value 0.109). Health outcome concerns (beta value -0.194) and food security and livelihoods (beta value 0.191). Conclusion: Three factors had a positive impact on treatment adherence namely, functional health systems, family support, and knowledge or understanding of health treatment, while two factors namely health outcome concerns and food security and livelihoods negatively impacted treatment adherence.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsCOVID-19HIV InfectionsMedication AdherenceAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSARS-CoV-2Young AdultZimbabweAnti-HIV AgentsAnti-Retroviral AgentsBulawayoHIV/AIDs patientsImpact of COVID-19-induced lockdownsZimbabwe

Identifiers

PMID40809568
PMCPMC12341185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.